Recent Updates
Recently added Catalysts
TNGX Neutral Sentiment

Tango Therapeutics to Report Second Quarter 2025 Financial Results on Tuesday, August 5, 2025

Key Takeaway: Tango Therapeutics, a clinical-stage biotechnology company, announced that it will report its second quarter 2025 financial results on August 5, 2025. The results will be published before the U.S. markets open, but the company has stated it will not hold a conference call to discuss the findings. Tango Therapeutics focuses on precision medicine for cancer treatment, utilizing synthetic lethality to devise novel therapies.
Price reaction · baseline $6.77 (2025-07-21 close) · hit after-hours · clean, no other TNGX news in the window
day 0 close · peak
-1.3%

Market Sentiment Analysis

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+24%
120-day peak, hindsight
Typical move
1%
average across 2 past catalysts
Cash runway
~78 mo
Minimal dilution risk
Lead asset
Perindopril-indapamide
Phase 3 · Diabetes Mellitus, Type 2

Full Press Release Details

BOSTON, July 22, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that it will report second quarter 2025 financial results on August 5, 2025, before the open of the U.S. financial markets. The company does not intend to hold a conference call.
About Tango Therapeutics
Tango Therapeutics is a clinical-stage biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. For more information, please visit www.tangotx.com.
Investors and Media:
Source: Tango Therapeutics, Inc.

Frequently Asked Questions

When will Tango Therapeutics report its Q2 2025 financial results?

Tango Therapeutics will report its Q2 2025 financial results on August 5, 2025.

Will there be a conference call after the financial report?

No, Tango Therapeutics does not plan to hold a conference call.

What is the focus of Tango Therapeutics?

Tango Therapeutics focuses on developing precision medicine for cancer treatment.

What principle does Tango Therapeutics utilize in drug discovery?

Tango Therapeutics uses the concept of synthetic lethality in their drug discovery.

Where can I find more information about Tango Therapeutics?

For additional information, visit Tango Therapeutics' website at www.tangotx.com.

Last updated: Jul 22, 2025